- Congresses
- IMCAS Asia - June 2025
- IMCAS China - July 2025
- IMCAS World Congress - January 2026
- IMCAS Americas - March 2026
- IMCAS Asia - June 2026
- Masterclasses
- IMCAS India - November 2025
- Congresses
- IMCAS Asia - June 2025
- IMCAS China - July 2025
- IMCAS World Congress - January 2026
- IMCAS Americas - March 2026
- IMCAS Asia - June 2026
- Masterclasses
- IMCAS India - November 2025

IMCAS Academy

Introduction
Program
Speakers
Sponsor list
Congress map
Accreditation

GO BACK

IMCAS Academy International
Program

Adapt the schedule of the livestreamed class/congress to your time zone

Time zone reference: (UTC-04:00) America, New York

Time zone

Time zone:Change time zone

If you are logged in, change your default time zone in your account

[EN, ES, IT, RU] Injectables: real integration or just tissue support? - (under educational grant from IBSA Farmaceutici)

Partner of the session

DASIL

The Dermatologic & Aesthetic Surgery International League

International

The Dermatologic & Aesthetic Surgery International League

The Mission of the Dermatologic & Aesthetic Surgery International League (DASIL) is to create a global community for the open exchange of knowledge and innovation by physicians specializing in Dermatologic and Aesthetic Surgery. Through our ongoing educational activities and by establishing a higher standard of care, people living around the world will benefit from safer, more effective dermatologic and aesthetics treatments.

Focus program

Room: Webinar
Date: Wednesday 7 April 2021 at 11:00 to 12:30
Format: FOCUS SESSION > lectures covering a major topic of the congress

Chair

Prof Daniel CASSUTO

Plastic Surgeon

Italy

Lectures of the session

Hours	Speakers	Lecture title	Abstract	Number
11:00		Simultaneous translation available in Spanish, Italian & Russian		110513
11:00	Dominique DU CREST	Introduction		108913
11:05	Dr Hema SUNDARAM	The new science of fillers: practical implications of hyaluronic acid rheology		108914
11:17	Prof Martina J KERSCHER	Hyaluronic acid for skin quality improvement: what can we achieve?		108915
11:29	Dr Pierre NICOLAU	Filler induced collagenesis and role in skin metabolism control	View	108916
11:41	Dr Ronald FEINER	Challenging cases from IMCAS Alert	View	109039
11:53		Q&A and discussion with the audience		108917

Go to previous day (Webinar)

Go to next day (Webinar)

Simultaneous translation available in Spanish, Italian & Russian

Dominique DU CREST

Industry Representative

France

Other author(s) :

Introduction

Dr Hema SUNDARAM

Dermatologist

United States

Other author(s) :

The new science of fillers: practical implications of hyaluronic acid rheology

Prof Martina J KERSCHER

Dermatologist

Germany

Other author(s) :

Hyaluronic acid for skin quality improvement: what can we achieve?

Dr Pierre NICOLAU

Plastic Surgeon

Spain

Other author(s) :

Filler induced collagenesis and role in skin metabolism control

Objectives: This presentation aims at explaining the complex mechanisms involved in Filler induced Collagenesis. Knowledge of these elements allows for a better understanding of the Mechanotranduction factors and of some of the adverse events encountered.

Materials / method: Knowledge of the anatomical and physiological changes induced by tension mechanisms within the skin allows us to understand the modifications in the "youth appearance" of the skin through fillers injections

Results: The concept of "tension integrity" or "tensegrity" is based on the knowledge of "mechanotransduction" mechanisms, through which mechanical forces are changed into chemical signals to modify and regulate the cells, mainly the fibroblast.
These mechanisms are well studied in wound healing, and are the same that applied to the consequences of the Foreign Body Reactions, occurring when fillers are injected within the tissues.

Conclusion: It is therefore possible to influence the skin metabolisms in order to recreate a softer, more elastic, younger skin.
But the type of the collagen produced has a major influence on the quality of the final results, and should be taken into account to avoid some or treat some complications.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
Yes
Please specify entities (individual, company, society): Sinclair Pharamceutical

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Dr Ronald FEINER

Australia

Other author(s) : Nil

Challenging cases from IMCAS Alert

Objectives: 3 challenging cases from IMCAS Alert are presented for consideration.

Introduction: The reliability of any particular filler integrating is dependent on several interrelated factors. For optimal integration, the intrinsic biochemical property of the filler utilised should ideally be matched to the recipient tissue histo/biological bed (and indeed the anatomical tissue plane) into which it is injected. For example, high viscosity fillers injected into the subcutaneous malar tissue plane can result in sub-optimal outcomes including complications such as chronic oedema and Tyndall effect.

Materials / method: 3 Case Studies

Results: Many ancillary factors need to be considered including sterile technique; instrumental mode of injection (i.e., needle or cannula); atraumatic delivery; the localised vascular challenge; patient age; patient co-morbidities and of course ambient communicable disease and immunisations (such as the current pandemic). The aesthetic objective should be well planned to minimise disappointment. For example, filler over use may result in a poorly integrated outcome. It may be better to aspire to an objective outcome in serial filling episodes rather than trying to achieve everything desired at once.

Conclusion: Many clinical complications and challenges are submitted by colleagues to IMCAS Alert facility.
Collegiate responses generate intense discussion and invaluable assistance to colleagues in need of assistance. It is anticipated that the 3 cases selected for this webinar will create interest for all participants.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Q&A and discussion with the audience

You have a question?

Quickly find your answer in our FAQ

Congresses

IMCAS Asia
IMCAS China
IMCAS World Congress
IMCAS Americas
IMCAS Asia

About

Company
Privacy Policy
Legal information

Academy

Home
Courses
Webinars
Explore
Blog

Grant

Educational grant

Get in touch

Username/Email

Password

Keep me logged in

Forgot password ? Do not have an account yet? Sign up now

Keep me logged in

academy.Do_not_have_an_account_yet Sign up now

IMCAS Academy International Program

[EN, ES, IT, RU] Injectables: real integration or just tissue support? - (*under educational grant from IBSA Farmaceutici*)

Chair

Lectures of the session

IMCAS Academy International
Program

[EN, ES, IT, RU] Injectables: real integration or just tissue support? - (under educational grant from IBSA Farmaceutici)